BindingDB logo
myBDB logout

Patent code US10000487

Compile Data Set for Download or QSAR
Found 21 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)		LigandTarget/Host
Links		Ligand
Links		Trg + Lig
Links		Ki
nM		ΔG°
kJ/mole		IC50
nM		Kd
nM		EC50/IC50
nM		koff
s-1		kon
M-1s-1		pHTemp
°C
MAP kinase-interacting serine/threonine-protein kinase 1/2


(Homo sapiens (Human))		BDBM400829
PNG
(6'-((1,2,5-thiadiazol-3-yl)amino)-8'-chloro-2'H-sp...)
Show SMILES Clc1cc(Nc2cnsn2)c(=O)n2c1C(=O)NC21CCCCC1
Show InChI InChI=1S/C14H14ClN5O2S/c15-8-6-9(17-10-7-16-23-19-10)13(22)20-11(8)12(21)18-14(20)4-2-1-3-5-14/h6-7H,1-5H2,(H,17,19)(H,18,21)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a<10n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
MAP kinase-interacting serine/threonine-protein kinase 1/2


(Homo sapiens (Human))		BDBM400830
PNG
(8'-chloro-6'-((2-methyl-2H-1,2,3-triazol-4-yl)amin...)
Show SMILES Cn1ncc(Nc2cc(Cl)c3C(=O)NC4(CCCCC4)n3c2=O)n1
Show InChI InChI=1S/C15H17ClN6O2/c1-21-17-8-11(20-21)18-10-7-9(16)12-13(23)19-15(22(12)14(10)24)5-3-2-4-6-15/h7-8H,2-6H2,1H3,(H,18,20)(H,19,23)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a<10n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
MAP kinase-interacting serine/threonine-protein kinase 1/2


(Homo sapiens (Human))		BDBM400834
PNG
(6'-((1,3,5-triazin-2-yl)amino)-8'-chloro-2'H-spiro...)
Show SMILES Clc1cc(Nc2ncncn2)c(=O)n2c1C(=O)NC21CCCCC1
Show InChI InChI=1S/C15H15ClN6O2/c16-9-6-10(20-14-18-7-17-8-19-14)13(24)22-11(9)12(23)21-15(22)4-2-1-3-5-15/h6-8H,1-5H2,(H,21,23)(H,17,18,19,20)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a<10n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
MAP kinase-interacting serine/threonine-protein kinase 1/2


(Homo sapiens (Human))		BDBM400811
PNG
(US10000487, Example 2F)
Show SMILES Clc1cc(Nc2ncns2)c(=O)n2c1C(=O)NC21CCCCC1
Show InChI InChI=1S/C14H14ClN5O2S/c15-8-6-9(18-13-16-7-17-23-13)12(22)20-10(8)11(21)19-14(20)4-2-1-3-5-14/h6-7H,1-5H2,(H,19,21)(H,16,17,18)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a<10n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
MAP kinase-interacting serine/threonine-protein kinase 1/2


(Homo sapiens (Human))		BDBM400832
PNG
(6'-((2H-1,2,3-triazol-4-yl)amino)-8'-chloro-2'H-sp...)
Show SMILES Clc1cc(Nc2cn[nH]n2)c(=O)n2c1C(=O)NC21CCCCC1
Show InChI InChI=1S/C14H15ClN6O2/c15-8-6-9(17-10-7-16-20-19-10)13(23)21-11(8)12(22)18-14(21)4-2-1-3-5-14/h6-7H,1-5H2,(H,18,22)(H2,16,17,19,20)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a<10n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
MAP kinase-interacting serine/threonine-protein kinase 1


(Homo sapiens (Human))		BDBM400832
PNG
(6'-((2H-1,2,3-triazol-4-yl)amino)-8'-chloro-2'H-sp...)
Show SMILES Clc1cc(Nc2cn[nH]n2)c(=O)n2c1C(=O)NC21CCCCC1
Show InChI InChI=1S/C14H15ClN6O2/c15-8-6-9(17-10-7-16-20-19-10)13(23)21-11(8)12(22)18-14(21)4-2-1-3-5-14/h6-7H,1-5H2,(H,18,22)(H2,16,17,19,20)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 55n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
MAP kinase-interacting serine/threonine-protein kinase 1/2


(Homo sapiens (Human))		BDBM400836
PNG
(6'-((2-aminopyridin-4-yl)amino)-8'-chloro-2'H-spir...)
Show SMILES Nc1cc(Nc2cc(Cl)c3C(=O)NC4(CCCCC4)n3c2=O)ccn1
Show InChI InChI=1S/C17H18ClN5O2/c18-11-9-12(21-10-4-7-20-13(19)8-10)16(25)23-14(11)15(24)22-17(23)5-2-1-3-6-17/h4,7-9H,1-3,5-6H2,(H,22,24)(H3,19,20,21)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 55n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
MAP kinase-interacting serine/threonine-protein kinase 1


(Homo sapiens (Human))		BDBM400811
PNG
(US10000487, Example 2F)
Show SMILES Clc1cc(Nc2ncns2)c(=O)n2c1C(=O)NC21CCCCC1
Show InChI InChI=1S/C14H14ClN5O2S/c15-8-6-9(18-13-16-7-17-23-13)12(22)20-10(8)11(21)19-14(20)4-2-1-3-5-14/h6-7H,1-5H2,(H,19,21)(H,16,17,18)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 55n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
MAP kinase-interacting serine/threonine-protein kinase 1/2


(Homo sapiens (Human))		BDBM400828
PNG
(8'-chloro-6'-(thiazol-5-ylamino)-2'H-spiro[cyclohe...)
Show SMILES Clc1cc(Nc2cncs2)c(=O)n2c1C(=O)NC21CCCCC1
Show InChI InChI=1S/C15H15ClN4O2S/c16-9-6-10(18-11-7-17-8-23-11)14(22)20-12(9)13(21)19-15(20)4-2-1-3-5-15/h6-8,18H,1-5H2,(H,19,21)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 55n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
MAP kinase-interacting serine/threonine-protein kinase 1/2


(Homo sapiens (Human))		BDBM400827
PNG
(US10000487, Example 4F)
Show SMILES Clc1cc(Nc2ncn[nH]2)c(=O)n2c1C(=O)NC21CCCCC1
Show InChI InChI=1S/C14H15ClN6O2/c15-8-6-9(18-13-16-7-17-20-13)12(23)21-10(8)11(22)19-14(21)4-2-1-3-5-14/h6-7H,1-5H2,(H,19,22)(H2,16,17,18,20)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 55n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
MAP kinase-interacting serine/threonine-protein kinase 1/2


(Homo sapiens (Human))		BDBM400805
PNG
(US10000487, Example 1F)
Show SMILES Clc1cc(Nc2nncs2)c(=O)n2c1C(=O)NC21CCCCC1
Show InChI InChI=1S/C14H14ClN5O2S/c15-8-6-9(17-13-19-16-7-23-13)12(22)20-10(8)11(21)18-14(20)4-2-1-3-5-14/h6-7H,1-5H2,(H,17,19)(H,18,21)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 55n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
MAP kinase-interacting serine/threonine-protein kinase 1/2


(Homo sapiens (Human))		BDBM400835
PNG
(6'-((1,2,4-triazin-3-yl)amino)-8'-chloro-2'H-spiro...)
Show SMILES Clc1cc(Nc2nccnn2)c(=O)n2c1C(=O)NC21CCCCC1
Show InChI InChI=1S/C15H15ClN6O2/c16-9-8-10(19-14-17-6-7-18-21-14)13(24)22-11(9)12(23)20-15(22)4-2-1-3-5-15/h6-8H,1-5H2,(H,20,23)(H,17,19,21)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 55n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
MAP kinase-interacting serine/threonine-protein kinase 1/2


(Homo sapiens (Human))		BDBM400833
PNG
(6'-((1,2,4-triazin-3-yl)amino)-8'-chloro-2'H-spiro...)
Show SMILES Clc1cc(Nc2cnncn2)c(=O)n2c1C(=O)NC21CCCCC1
Show InChI InChI=1S/C15H15ClN6O2/c16-9-6-10(20-11-7-18-19-8-17-11)14(24)22-12(9)13(23)21-15(22)4-2-1-3-5-15/h6-8H,1-5H2,(H,21,23)(H,17,19,20)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 55n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
MAP kinase-interacting serine/threonine-protein kinase 1/2


(Homo sapiens (Human))		BDBM400826
PNG
(6'-((1,2,3-thiadiazol-5-yl)amino)-8'-chloro-2'H-sp...)
Show SMILES Clc1cc(Nc2cnns2)c(=O)n2c1C(=O)NC21CCCCC1
Show InChI InChI=1S/C14H14ClN5O2S/c15-8-6-9(17-10-7-16-19-23-10)13(22)20-11(8)12(21)18-14(20)4-2-1-3-5-14/h6-7,17H,1-5H2,(H,18,21)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 55n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
MAP kinase-interacting serine/threonine-protein kinase 1


(Homo sapiens (Human))		BDBM400827
PNG
(US10000487, Example 4F)
Show SMILES Clc1cc(Nc2ncn[nH]2)c(=O)n2c1C(=O)NC21CCCCC1
Show InChI InChI=1S/C14H15ClN6O2/c15-8-6-9(18-13-16-7-17-20-13)12(23)21-10(8)11(22)19-14(21)4-2-1-3-5-14/h6-7H,1-5H2,(H,19,22)(H2,16,17,18,20)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a>5.05E+3n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
MAP kinase-interacting serine/threonine-protein kinase 1/2


(Homo sapiens (Human))		BDBM400831
PNG
(6'-((1,3,4-oxadiazol-2-yl)amino)-8'-chloro-2'H-spi...)
Show SMILES Clc1cc(Nc2nnco2)c(=O)n2c1C(=O)NC21CCCCC1
Show InChI InChI=1S/C14H14ClN5O3/c15-8-6-9(17-13-19-16-7-23-13)12(22)20-10(8)11(21)18-14(20)4-2-1-3-5-14/h6-7H,1-5H2,(H,17,19)(H,18,21)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a>5.05E+3n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
MAP kinase-interacting serine/threonine-protein kinase 1


(Homo sapiens (Human))		BDBM400828
PNG
(8'-chloro-6'-(thiazol-5-ylamino)-2'H-spiro[cyclohe...)
Show SMILES Clc1cc(Nc2cncs2)c(=O)n2c1C(=O)NC21CCCCC1
Show InChI InChI=1S/C15H15ClN4O2S/c16-9-6-10(18-11-7-17-8-23-11)14(22)20-12(9)13(21)19-15(20)4-2-1-3-5-15/h6-8,18H,1-5H2,(H,19,21)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a>5.05E+3n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
MAP kinase-interacting serine/threonine-protein kinase 1


(Homo sapiens (Human))		BDBM400831
PNG
(6'-((1,3,4-oxadiazol-2-yl)amino)-8'-chloro-2'H-spi...)
Show SMILES Clc1cc(Nc2nnco2)c(=O)n2c1C(=O)NC21CCCCC1
Show InChI InChI=1S/C14H14ClN5O3/c15-8-6-9(17-13-19-16-7-23-13)12(22)20-10(8)11(21)18-14(20)4-2-1-3-5-14/h6-7H,1-5H2,(H,17,19)(H,18,21)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a>5.05E+3n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
MAP kinase-interacting serine/threonine-protein kinase 1


(Homo sapiens (Human))		BDBM400805
PNG
(US10000487, Example 1F)
Show SMILES Clc1cc(Nc2nncs2)c(=O)n2c1C(=O)NC21CCCCC1
Show InChI InChI=1S/C14H14ClN5O2S/c15-8-6-9(17-13-19-16-7-23-13)12(22)20-10(8)11(21)18-14(20)4-2-1-3-5-14/h6-7H,1-5H2,(H,17,19)(H,18,21)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a>5.05E+3n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
MAP kinase-interacting serine/threonine-protein kinase 1


(Homo sapiens (Human))		BDBM400835
PNG
(6'-((1,2,4-triazin-3-yl)amino)-8'-chloro-2'H-spiro...)
Show SMILES Clc1cc(Nc2nccnn2)c(=O)n2c1C(=O)NC21CCCCC1
Show InChI InChI=1S/C15H15ClN6O2/c16-9-8-10(19-14-17-6-7-18-21-14)13(24)22-11(9)12(23)20-15(22)4-2-1-3-5-15/h6-8H,1-5H2,(H,20,23)(H,17,19,21)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a>1.00E+7n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
MAP kinase-interacting serine/threonine-protein kinase 1


(Homo sapiens (Human))		BDBM400826
PNG
(6'-((1,2,3-thiadiazol-5-yl)amino)-8'-chloro-2'H-sp...)
Show SMILES Clc1cc(Nc2cnns2)c(=O)n2c1C(=O)NC21CCCCC1
Show InChI InChI=1S/C14H14ClN5O2S/c15-8-6-9(17-10-7-16-19-23-10)13(22)20-11(8)12(21)18-14(20)4-2-1-3-5-14/h6-7,17H,1-5H2,(H,18,21)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a>1.00E+7n/an/an/an/an/an/a



eFFECTOR Therapeutics Inc

US Patent


Assay Description
Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...

US Patent US10000487 (2018)


Article DOI: null
BindingDB Entry DOI: 10.7270/Q2KP84H6
More data for this
Ligand-Target Pair
* indicates data uncertainty>20%